ACUTE CHANGES OF ENERGETIC SUBSTRATES ON MIOCARDIAL FUNCTION AND METABOLISM, IN PATIENTS WITH CRONIC HEART FAILURE ACITRIM - ND
- Conditions
- HEART FAILUREMedDRA version: 9.1Level: HLGTClassification code 10019280Term: Heart failures
- Registration Number
- EUCTR2007-000763-18-IT
- Lead Sponsor
- OSPEDALE S. RAFFAELE
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 10
PATIENTS WITH CHRONIC CARDIAC FAILURE CLASS NYHA II-III WITH SYMPTOMS EVEN IF UNDER TREATMENT FROM AT LEAST 3 MONTHS WITH STABLE DOSE FROM AT LEAST 4 WEEKS;TREATMENT WITH BETA BLOCKERS OR ACE INHIBITORS STARTED FROM 3 MONTHS OR MORE;EJECTION FRACTION MORE OR EQUAL TO 40 PROVED BY TRANSTORACIC ECO
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
MIOCARDIAC STROKE OR INSTABLE ANGINA WITHIN 3 MONTHS BEFORE ENROLLMENT;ALCOOL ABUSE;CONGESTIVE CARDIAC HEART FAILURE;SEVERE ARITMIA;DISEASE IN COAGULATION;SEVERE RENAL INSUFFICIENCY;CARDIAC ISCHEMAI DURING ENFORCED TEST;DIABETE MELLITUS;ACTIVE NEOPLASTIC PROCESSES;ETC
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: TO EVALUATE THE CHANGES IN CARDIAC METABOLISM AND CARDIAC ENERGETIC PREFERENCES AFTER EXTERNAL ADMINISTRATION OF FATTY ACIDS,ACIPIMOX O TMZ ALONE OR PUT TOGETHER;Secondary Objective: TO EVALUATE THE CHANGES IN CARDIAC METABOLISM AND CARDIAC ENERGETIC PREFERENCES AFTER EXTERNAL ADMINISTRATION OF FATTY ACIDS,ACIPIMOX O TMZ ALONE OR PUT TOGETHER;Primary end point(s): TO EVALUATE THE CHANGES IN CARDIAC METABOLISM AND CARDIAC ENERGETIC PREFERENCES AFTER EXTERNAL ADMINISTRATION OF FATTY ACIDS,ACIPIMOX O TMZ ALONE OR PUT TOGETHER
- Secondary Outcome Measures
Name Time Method